ENDRA Life Sciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- ENDRA Life Sciences Inc.
- Former names
- Endra Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- ANN Arbor
- Headquarters state / province
- Michigan
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NDRA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001681682
- EIN
- 26-0579295
Board of directors
-
Alexander Y. Tokman · Director · Chief Executive OfficerSince 2023
- Since 2023
-
Francois Roger Michelon · Director · Chief Executive OfficerSince 2023
-
Lou Basenese · DirectorSince 2023
-
Michael Harsh · DirectorSince 2023
Chief executives
Francois Roger Michelon
· Chief Executive Officer
Dates unknown
Alexander Y. Tokman
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of December 9, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.0%
-
98.3%
-
98.3%
-
99.3%
Board connections
2 of this board's directors also sit on 4 other boards.
- via Anthony Digiandomenico and Lou Basenese
- via Anthony Digiandomenico
- via Anthony Digiandomenico
- via Anthony Digiandomenico
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Alexander Y. Tokman Director, Officer (Chief Executive Officer) | Grant or award | +26,921 | — | — |
| Mar 2, 2026 | Jacroux Richard Officer (Chief Financial Officer) | Grant or award | +13,461 | — | — |
| Jan 21, 2026 | Anthony Digiandomenico Director | Grant or award | +60,324 | — | — |
| Jan 21, 2026 | Michael Harsh Director | Grant or award | +60,324 | — | — |
| Jan 21, 2026 | Jacroux Richard Officer (Chief Financial Officer) | Grant or award | +20,000 | — | — |
| Jan 21, 2026 | Lou Basenese Director | Grant or award | +60,324 | — | — |
| Jan 21, 2026 | Alexander Y. Tokman Director, Officer (Chief Executive Officer) | Grant or award | +75,000 | — | — |
| Oct 10, 2025 | Anthony Digiandomenico Director | Grant or award | +70,822 | $7.06 | $500,003 |
| Jun 11, 2025 | Lou Basenese Director | Grant or award | +5,384 | — | — |
| Jun 11, 2025 | Michael Harsh Director | Grant or award | +5,384 | — | — |
| Jun 11, 2025 | Anthony Digiandomenico Director | Grant or award | +5,384 | — | — |
| Aug 27, 2024 | UBS Group AG 10% owner | Open-market purchase | +3,715 | $0.55 | $2,043 |
| May 18, 2023 | Thornton Michael Milos Officer (Chief Technology Officer) | Open-market purchase | +15,000 | $1.65 | $24,750 |
| May 2, 2023 | Anthony Digiandomenico Director | Open-market purchase | +83,333 | $1.20 | $100,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.